Application 209680
- Type
- ANDA
- Sponsor
- YUNG SHIN PHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ELETRIPTAN HYDROBROMIDE | ELETRIPTAN HYDROBROMIDE | TABLET;ORAL | EQ 20MG BASE | No | No |
| 002 | ELETRIPTAN HYDROBROMIDE | ELETRIPTAN HYDROBROMIDE | TABLET;ORAL | EQ 40MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209680-001 | ELETRIPTAN HYDROBROMIDE | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | ||
| A209680-002 | ELETRIPTAN HYDROBROMIDE | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | 4b0b4de00fa7… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A209680-001 | ELETRIPTAN HYDROBROMIDE | EQ 20MG BASE | TABLET / ORAL | 2020-07-13 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A209680-002 | ELETRIPTAN HYDROBROMIDE | EQ 40MG BASE | TABLET / ORAL | 2020-07-13 | bb7c543d1eb4… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.